HERON THERAPEUTICS, INC. /DE/ (HRTX) Return On Assets % [USD] 2012 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Return On Assets history and growth rate from 2012 to 2024.
  • Heron Therapeutics, Inc. /De/ Return On Assets for the quarter ending March 31, 2024 was -37.2 %, a 39.2% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Return On Assets for 2023 was -50.6 %, a 27.7% increase from 2022.
  • Heron Therapeutics, Inc. /De/ annual Return On Assets for 2022 was -70 %, a 8.85% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Return On Assets for 2021 was -64.3 %, a 17% decline from 2020.
Return On Assets, Quarterly (% [USD])
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -37.2 +23.9 +39.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -50.6 +19.4 +27.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -53.1 +26.1 +33% Jul 1, 2023 Sep 30, 2023
Q2 2023 -57.8 +19.5 +25.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -61.1 +8.33 +12% Jan 1, 2023 Mar 31, 2023
Q4 2022 -70 -5.69 -8.85% Oct 1, 2022 Dec 31, 2022
Q3 2022 -79.2 -14.9 -23.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -77.3 -13.1 -20.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -69.4 -8.04 -13.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -64.3 -9.36 -17% Oct 1, 2021 Dec 31, 2021
Q3 2021 -64.3 -15.1 -30.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -64.2 -20.6 -47.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -61.4 -18.4 -42.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -54.9 -8.21 -17.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -49.1 -3 -6.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -43.6 +1.55 +3.43% Apr 1, 2020 Jun 30, 2020
Q1 2020 -43.1 -2.7 -6.69% Jan 1, 2020 Mar 31, 2020
Q4 2019 -46.7 -2.75 -6.26% Oct 1, 2019 Dec 31, 2019
Q3 2019 -46.1 +8.69 +15.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -45.2 +29.5 +39.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -40.4 +77.3 +65.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -44 +71.5 +61.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -54.8 +86.6 +61.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -74.7 +77.6 +51% Apr 1, 2018 Jun 30, 2018
Q1 2018 -118 +54.5 +31.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -115 +74.9 +39.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -141 +2.7 +1.87% Jul 1, 2017 Sep 30, 2017
Q2 2017 -152 -46.4 -43.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -172 -96.5 -128% Jan 1, 2017 Mar 31, 2017
Q4 2016 -190 -117 -159% Oct 1, 2016 Dec 31, 2016
Q3 2016 -144 -70.2 -95.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 -106 -23.4 -28.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -75.6 +18.6 +19.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -73.4 +16.4 +18.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -73.9 +8.31 +10.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -82.5 +10.3 +11.1% Apr 1, 2015 Jun 30, 2015
Q1 2015 -94.2 +23.7 +20.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -89.7 +27 +23.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -82.2 +33.5 +28.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 -92.7 -10.3 -12.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 -118 -48.5 -69.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -117 -31.4 -36.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 -116 -14.6 -14.4% Jul 1, 2013 Sep 30, 2013
Q2 2013 -82.5 +65 +44.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 -69.4 +49.8 +41.8% Jan 1, 2013 Mar 31, 2013
Q4 2012 -85.4 Oct 1, 2012 Dec 31, 2012
Q3 2012 -101 Jul 1, 2012 Sep 30, 2012
Q2 2012 -148 Apr 1, 2012 Jun 30, 2012
Q1 2012 -119 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.